MicroGenDX
Dave Roye is a versatile professional with extensive experience in software development and healthcare. Currently serving as a Software Developer at MicroGenDX since September 2021, Dave specializes in qPCR and NGS microbial DNA diagnostics. Prior to this role, Dave engaged in remote software development and support while seeking new opportunities, and previously worked as a Registered Nurse at Covenant Health. An accomplished software engineer, Dave has held various positions at notable companies including Good Powered by BlackBerry, L-3 Communications, Carrollton, Nokia, Primeco Personal Communications, and DSC, accumulating a broad skill set in software engineering, technical support, and project leadership. Educational qualifications include a Master's in Electrical Engineering from Texas Tech University, a Nanodegree in Cloud Development from Udacity, a Bachelor's degree in Nursing from Texas Tech University Health Sciences Center, and a Bachelor's degree in Petroleum Engineering from The University of Texas at Austin.
This person is not in any offices
MicroGenDX
MicroGenDX provides qPCR+NGS sequencing for the detection of infectious diseases. The American Medical Association (AMA) and Medicare have issued a billing code to MicroGenDX to provide this testing service, recognizing this technology as medically necessary. MicroGenDX is trusted by over 39,000 physicians worldwide and has helped over 900,000 patients with diagnostic testing for their chronic and life-threatening infections. MicroGenDX is a College of American Pathologists (CAP) accredited and Clinical Laboratory Improvements Amendments (CLIA) licensed clinical laboratory. Tens of thousands of patients with chronic and often life-threatening infections have benefited from MicroGenDX’s work. MicroGenDX's NGS technology offers several advantages over traditional culture-based methods for identifying microorganisms. It can detect a wider range of microorganisms, including those that are difficult to culture or grow in a laboratory. It also provides more accurate and comprehensive results, as it can detect multiple microorganisms in a single sample and identify them at the species or strain level. Additionally, NGS technology is faster than traditional methods, allowing for quicker diagnosis and treatment decisions. MicroGenDX's testing services are used in a variety of settings, including hospitals, long-term care facilities, dental offices, and veterinary clinics. Their technology has been applied to a wide range of clinical conditions, including chronic wounds, orthopedic infections, respiratory infections, and urinary tract infections, among others.